A207 RIPK2 AND AMPK AS EMERGING THERAPEUTIC TARGETS FOR INFLAMMATORY BOWEL DISEASE

BACKGROUND: Persistent inflammation can trigger altered epigenetic, inflammation and bioenergetics states. Inflammatory bowel disease (IBD) is a heterogeneous disease with an abnormal inflammatory state and subsequent metabolic syndrome disorder. Current IBD therapeutics are directed to inhibit infl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Can Assoc Gastroenterol
Main Authors: Guo, Y, Dieleman, L A, Dooky, H, Joshi, H, Wine, E, Baksh, S
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Poster Presentation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7043684/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz047.206
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados